Clinical Trials
3 trialsNCT03506373 2026-05-05
Ibrutinib and Ixazomib Citrate in Treating Newly Diagnosed, Relapsed or Refractory Waldenstrom Macroglobulinemia
Mayo Clinic
Phase 2 Terminated
NCT03502577 2024-01-08
BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma
Fred Hutchinson Cancer Center
Phase 1 Terminated
NCT03557970 2021-12-02
JNJ-40346527 in Treating Participants With Relapsed or Refractory Acute Myeloid Leukemia
OHSU Knight Cancer Institute
Phase 2 Terminated